These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 23666586)
1. Re: Percutaneous nephrostomy for malignant ureteric obstruction: have we got the balance right? Bissada NK; Kamel MH Int Urol Nephrol; 2013 Jun; 45(3):633. PubMed ID: 23666586 [No Abstract] [Full Text] [Related]
2. Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right? Misra S; Coker C; Richenberg J Int Urol Nephrol; 2013 Jun; 45(3):627-32. PubMed ID: 23666587 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous nephrostomy in the management of malignant ureteric obstruction. Teenan RP; Ramsay A; Deane RF Br J Urol; 1989 Sep; 64(3):238-40. PubMed ID: 2804559 [TBL] [Abstract][Full Text] [Related]
4. Use of percutaneous nephrostomy in malignant ureteric obstruction. Chapman ME; Reid JH Br J Radiol; 1991 Apr; 64(760):318-20. PubMed ID: 2025771 [TBL] [Abstract][Full Text] [Related]
5. Percutaneous nephrostomy for malignant ureteral obstruction in children. Report of six cases. Montagne JP; Couanet D; Geoffray A; Neuenschwander S Ann Radiol (Paris); 1986; 29(3-4):401-5. PubMed ID: 3752880 [No Abstract] [Full Text] [Related]
6. The management of ureteric obstruction secondary to malignant pelvic disease. Chitale SV; Scott-Barrett S; Ho ET; Burgess NA Clin Radiol; 2002 Dec; 57(12):1118-21. PubMed ID: 12475538 [TBL] [Abstract][Full Text] [Related]
7. Self-expanding wallstent endoprosthesis for malignant ureteral obstruction. Díaz-Lucas EF; Martínez-Torres JL; Fernández Mena J; Carazo Martínez O; de la Fuente Serrano A; Zuluaga Gómez A J Endourol; 1997 Dec; 11(6):441-7. PubMed ID: 9440854 [TBL] [Abstract][Full Text] [Related]
8. The role of percutaneous nephrostomy in malignant ureteric obstruction. Wilson JR; Urwin GH; Stower MJ Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902 [TBL] [Abstract][Full Text] [Related]
15. Re: Outcome of retrograde ureteric stenting as a urinary drainage procedure in ureteric obstruction related to malignant lesions. Goonewardena SA; Vickneswaran K Ceylon Med J; 2015 Jun; 60(2):75-6. PubMed ID: 26132194 [No Abstract] [Full Text] [Related]
16. Ureteral obstruction and stents: still a difficult problem for patients and urologists alike. Russo P J Urol; 2005 Dec; 174(6):2088. PubMed ID: 16280733 [No Abstract] [Full Text] [Related]
17. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences? Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473 [TBL] [Abstract][Full Text] [Related]
20. Use of nephrostomy tubes in ureteric obstruction from incurable malignancy. Little B; Ho KJ; Gawley S; Young M Int J Clin Pract; 2003 Apr; 57(3):180-1. PubMed ID: 12723719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]